RA
PFE icon

Riversedge Advisors’s Pfizer PFE Stock Holding History

Riversedge Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810K Buy
28,400
+17,180
+153% +$457K 0.1% 88
2026
Q2 		$270K Buy
+11,220
New +$293K 0.04% 231

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Riversedge Advisors's PFE Position: Q3 2026 in Review

Riversedge Advisors increased its Pfizer (PFE) stake by 153% in Q3 2026, buying an estimated $457K and bringing the position to 28,400 shares worth $810K. The position accounts for 0.1% of the portfolio, ranked #88.

Riversedge Advisors first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 415 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Riversedge Advisors held 28,400 shares of Pfizer worth $810K as of Q3 2026.
  • Riversedge Advisors bought 17,180 Pfizer shares in Q3 2026, an estimated $457K.
  • Pfizer made up 0.1% of Riversedge Advisors's portfolio in Q3 2026, its #88 holding.
  • Riversedge Advisors first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
  • 415 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.